779 results Transition Finance Transition finance provides options for borrowers and issuers who are not able or willing to commit to green and sustainability principles in their financing options, as they are transitioning their businesses onto the path towards a sustainable future. The Stibbe Annual Competition Update will take place on 24 January 2023 2023 will be the end game of the European Commission’s competition policy review. Shiny new competition policy tools for dealing with social, digital and vertical aspects as well as foreign investment issues are upcoming, ongoing or being finalised. FSR zorgt voor nieuwe uitdagingen bij transacties en aanbestedingen Op 12 januari van dit jaar trad de Foreign Subsidies Regulation (FSR) in werking, die per 12 oktober een meldplicht bij de Europese Commissie voor bepaalde transacties en aanbestedingen introduceert. Dutch national security screening regime enters into force The Dutch national security screening regime (Wet veiligheidstoets investeringen, fusies en overnames or Wet Vifo) enters into force today, 1 June. Levelling the playing field in 2023: new tools and hurdles While 2022 revolved around new and improved regulatory tools, the focus in 2023 will be on putting these tools to use. More merger-related obligations, digital sector scrutiny and clarity on competition-law and consumer-law aspects is imminent. C'est le ton qui fait la musique – The end of employer copyrights? The CJEU decision in the National Orchestra of Belgium decision shakes up employer copyright in the Netherlands. With new consent and compensation requirements, are your employment contracts still airtight? Discover the implications of the decision here. The long and (un)winding road of ‘killer acquisition’ Illumina/Grail Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a day’s work for the European Commission. Innovation was a recurring theme in the Commission’s handling of the Illumina/Grail deal. If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug. The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines. Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement. Webinar Clean Industrial State Aid Framework (CISAF) Op 11 november van 12:00 tot 13:00 uur organiseert Stibbe een webinar over het Clean Industrial State Aid Framework (CISAF), het nieuwe Europese staatssteunraamwerk voor industriële vergroening. De Omnibus I: wat betekent de stemming in het Europees Parlement over de CSRD en CSDDD voor Nederlandse ondernemingen? De Omnibus I zet de Europese duurzaamheidsregels opnieuw op scherp. In deze podcast bespreken Loes van Dijk en Rogier Raas de politieke dynamiek, de gevolgen voor de CSRD en CSDDD en wat dit betekent voor Nederlandse bedrijven. RIE vs. CSRD: rapportageverplichtingen voor industriële bedrijven In deze Stibbe Legal Insights leggen we de rapportageverplichtingen uit de herziene Richtlijn Industriële Emissies naast die van de Corporate Sustainability Reporting Directive. Industriële bedrijven krijgen met beide te maken. Tom Verdonk Associate Amsterdam Ali al Khatib Senior Associate Amsterdam Fanny Parmentier Junior Associate Brussels Noor Dewulf Junior Associate Brussels Anneleen Quirynen Partner Brussels Pagination Previous page Page 31 Current page 32 Page 33 Page 34 Next page
Transition Finance Transition finance provides options for borrowers and issuers who are not able or willing to commit to green and sustainability principles in their financing options, as they are transitioning their businesses onto the path towards a sustainable future.
The Stibbe Annual Competition Update will take place on 24 January 2023 2023 will be the end game of the European Commission’s competition policy review. Shiny new competition policy tools for dealing with social, digital and vertical aspects as well as foreign investment issues are upcoming, ongoing or being finalised.
FSR zorgt voor nieuwe uitdagingen bij transacties en aanbestedingen Op 12 januari van dit jaar trad de Foreign Subsidies Regulation (FSR) in werking, die per 12 oktober een meldplicht bij de Europese Commissie voor bepaalde transacties en aanbestedingen introduceert.
Dutch national security screening regime enters into force The Dutch national security screening regime (Wet veiligheidstoets investeringen, fusies en overnames or Wet Vifo) enters into force today, 1 June.
Levelling the playing field in 2023: new tools and hurdles While 2022 revolved around new and improved regulatory tools, the focus in 2023 will be on putting these tools to use. More merger-related obligations, digital sector scrutiny and clarity on competition-law and consumer-law aspects is imminent.
C'est le ton qui fait la musique – The end of employer copyrights? The CJEU decision in the National Orchestra of Belgium decision shakes up employer copyright in the Netherlands. With new consent and compensation requirements, are your employment contracts still airtight? Discover the implications of the decision here.
The long and (un)winding road of ‘killer acquisition’ Illumina/Grail Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a day’s work for the European Commission. Innovation was a recurring theme in the Commission’s handling of the Illumina/Grail deal.
If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.
The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines.
Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement.
Webinar Clean Industrial State Aid Framework (CISAF) Op 11 november van 12:00 tot 13:00 uur organiseert Stibbe een webinar over het Clean Industrial State Aid Framework (CISAF), het nieuwe Europese staatssteunraamwerk voor industriële vergroening.
De Omnibus I: wat betekent de stemming in het Europees Parlement over de CSRD en CSDDD voor Nederlandse ondernemingen? De Omnibus I zet de Europese duurzaamheidsregels opnieuw op scherp. In deze podcast bespreken Loes van Dijk en Rogier Raas de politieke dynamiek, de gevolgen voor de CSRD en CSDDD en wat dit betekent voor Nederlandse bedrijven.
RIE vs. CSRD: rapportageverplichtingen voor industriële bedrijven In deze Stibbe Legal Insights leggen we de rapportageverplichtingen uit de herziene Richtlijn Industriële Emissies naast die van de Corporate Sustainability Reporting Directive. Industriële bedrijven krijgen met beide te maken.